The Experts in Animal Health

printer friendly

Brakke Consulting’s
Animal Health News & Notes for September 4, 2015

Copyright © Brakke Consulting, Inc.
Editor: Lynn Fondon DVM MBA
Brakke Consulting news
earnings news
Nexvet Biopharma
other news
ISL Animal Health
NJ Phillips PTY
Vestwest Limited
Zoetis (Lutalyse)
Zoetis (Trocoxil)

The best place on the web to find qualified job applicants! is now in its 9th year of operation. It has become an exceptional and mature capability for your recruiting efforts. has grown to include over 27,000 pre-qualified job seekers, and consistently maintains a high degree of talent: 66% of our registered users have a Bachelor’s degree, and 21% have some kind of advanced degree. has recently achieved new records for the number of job postings on the site, so when you are seeking the best, come to – first. 

> Krka reported financial results for the first half of 2015. Animal health sales came to EUR 26 million ($29.3 million), a 15% increase compared to the first half of 2014. (Animal Pharm) 
> Nexvet Biopharma announced financial results for its 2015 fiscal year, ended June 30th. The company reported a net loss attributable to common shareholders of $(11.9) million compared to $(6.7) million for the year ended June 30, 2014. For the years ended June 30, 2015 and 2014, other income comprised research and development incentive income of $3.5 million and $2.3 million, respectively, government grant income of $0.4 million and $1.3 million, respectively; and an exchange gain of $4.2 million and an exchange loss of $0.4 million respectively. (CNN Money)
> The FDA announced approval of Zoetis’ Lutalyse HighCon Injection (dinoprost tromethamine) for use in dairy and beef cows and heifers. (FDA) 
> The FDA announced approval of Novartis’ (now Elanco) Onsior (robenacoxib) subcutaneous injection for control of postoperative pain in cats. (FDA)  
> Greenies announced the launch of a veterinary-exclusive, reformulation of the popular Greenies chew. The new dental care product is also are infused with ingredients supporting cognitive, immune, metabolic and skin health. (Vet Advantage)
> Avivagen announced that its Vivamune Vital Health3 Chews are now available to pet retailers in the US. Until now, the products could only be ordered online. ( 
> French animal health firm VitamFero announced it has signed an exclusive, worldwide agreement for its animal toxoplasmosis vaccine with Australian company Bioproperties. The live, attenuated vaccine will be transferred to Bioproperties, which will oversee manufacturing and the ongoing development of the product, and will manage the vaccine’s development up until drug registration and launch. The first market approval is expected to be an ovine toxoplasmosis vaccine. Financial terms were not disclosed. (Animal Pharm) 
> Vet24seven announced it has launched PetCheck, a new in-home service for animal owners and their companions. Pet parents can now schedule a veterinarian consultation at their convenience for a $75 per pet fee. PetCheck includes a one-time home visit, comprehensive physical exam, nutrition evaluation, oral hygiene evaluation, household toxins evaluation and more. PetCheck is currently piloting in California. (Vet Advantage)
> UK  AmerisourceBergen announced that MWI Veterinary Supply has acquired Vestwest Limited, a provider of buying group and ancillary services to member veterinary practice across the UK. Financial terms were not disclosed. (
> JAPAN   The Japanese Ministry of Agriculture, Forestry and Fisheries (JMAFF) announced marketing approval for Zoetis’ Trocoxil (mavacoxib) Chewable for the relief of pain and inflammation associated with degenerative joint disease in dogs. Trocoxil is already marketed in Europe, where it was launched in 2009. (Animal Pharm)
> EU  Premune and Innovet announced that they have entered into an exclusive licensing agreement for Redonyl Ultra, a nutritional supplement based on PEA-um (ultramicronized palmitoylethanolamide) to support healthy skin in dogs and cats. The license gives Premune exclusive marketing rights for Redonyl Ultra in major European markets outside of Italy, plus an option for introducing the product in North America at a later date. Financial terms were not disclosed. (PRNewswire)
> AUSTRALIA/NEW ZEALAND  Simcro Limited announced it has acquired ISL Animal Health (Hamilton, NZ) and NJ Phillips PTY (NSW, Australia). Financial terms were not disclosed. (company press release) 
> NORWAY  Pharmaq announced the formation of Pharmaq Analytiq, a diagnostics division for fish farmers. The company offers 30 plus available assays to meet customer demand for pathogen surveillance. (Animal Pharm) 
> US – VESICULAR STOMATITIS  This summer’s outbreak of vesicular stomatitis (VS) has affected 279 premises as of August 19, according to the USDA’s Animal and Plant Health Inspection Service (APHIS). Confirmed cases have occurred in seven states – Arizona, Colorado, New Mexico, South Dakota, Texas, Utah and Wyoming. Colorado has seen the most cases so far this year; most confirmed cases have been on equine premises. (Vet Advantage)
> US – SWINE FACILITIES  The Arkansas Pollution Control and Ecology Commission has approved a temporary 5-year ban on new medium and large hog farms in the Buffalo River Watershed. No farm can have more than 3,000 swine. The 5-year ban is a compromise among environmentalists, the Arkansas governor and state lawmakers. (Vet Advantage)
The news is a little light this week because EVERYONE was in Kansas City. There were 1,010 people at the Homecoming Dinner on Monday night. That’s quite an increase from the 135 at the first Homecoming 10 years ago. The Corridor has undeniably achieved worldwide recognition as the center for animal health activity. The Investment Forum was also well attended, with 400 people learning about 17 companies that are in the early development stage. Congratulations to Kimberly Young and Emily McVey and the rest of their team.

I would be remiss not to take note of one or two items in the news that show how reaching the pet owner is changing. House calls by veterinarians have not been unknown, but it seems that at least one company believes they can make home visits part of a wellness program. Also, we have a product line going from Internet-only sales into retailers. The days of getting store distribution as a critical first step in product introduction may be fading.

For our US readers, enjoy your holiday weekend.
John Mannhaupt
This electronic newsletter is the sole property of Brakke Consulting, Inc.
Any use of the contents herein should be approved by and appropriately attributed to Brakke Consulting, Inc.
For more information about Brakke Consulting’s services and syndicated studies, visit our website at
Brakke Consulting, Inc.
12005 Ford Rd., Suite 530
Dallas, TX  75234    USA


en_USEnglish (United States)